← Back to Search

HIIT for Reducing Frailty in Older Veterans (HIIT@Home Trial)

N/A
Recruiting
Led By Bruce R. Troen, MD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline to endpoint at 12 weeks
Awards & highlights

HIIT@Home Trial Summary

This trial is studying how high intensity exercise can help older people stay physically active and healthy as they age.

Who is the study for?
This trial is for older veterans, both male and female of any race, who are at least 60 years old. Participants should be non-frail or pre-frail with a frailty score less than 3 and must be medically cleared to exercise. Those with severe COPD, advanced kidney disease, extreme high blood pressure, or significant cognitive impairment cannot join.Check my eligibility
What is being tested?
The study is testing the effects of different types of High Intensity Interval Training (HIIT) on reducing frailty and enhancing resilience in older adults. It compares center-based HIIT, home-based HIIT against a control group receiving standard attention without intensive training.See study design
What are the potential side effects?
While specific side effects are not listed for this type of physical intervention, general risks may include muscle soreness, fatigue after workouts, increased risk of falls during exercise sessions and potential exacerbation of underlying health conditions.

HIIT@Home Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline to endpoint at 12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline to endpoint at 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Body Composition (Lean and fat mass)
C-Reactive Protein
Frailty assessment
+8 more
Secondary outcome measures
Amyloid beta 42/40 ratio
Anxiety and depression
Brain Derived Neurotrophic Factor (BDNF)
+10 more

HIIT@Home Trial Design

3Treatment groups
Experimental Treatment
Group I: Home based HIITExperimental Treatment1 Intervention
Home based HIIT
Group II: Center based attention controlExperimental Treatment1 Intervention
Center based attention control
Group III: Center based HIITExperimental Treatment1 Intervention
Center based HIIT

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,609 Previous Clinical Trials
3,306,253 Total Patients Enrolled
9 Trials studying Frailty
30,664 Patients Enrolled for Frailty
Bruce R. Troen, MDPrincipal InvestigatorKansas City VA Medical Center, Kansas City, MO
2 Previous Clinical Trials
78 Total Patients Enrolled
2 Trials studying Frailty
78 Patients Enrolled for Frailty

Media Library

Center based HIIT Clinical Trial Eligibility Overview. Trial Name: NCT05625204 — N/A
Frailty Research Study Groups: Center based attention control, Center based HIIT, Home based HIIT
Frailty Clinical Trial 2023: Center based HIIT Highlights & Side Effects. Trial Name: NCT05625204 — N/A
Center based HIIT 2023 Treatment Timeline for Medical Study. Trial Name: NCT05625204 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does my medical history make me a suitable candidate for this trial?

"This research is targeting 200 elderly individuals aged between 60 to 85 and who are classified as either non-frail or pre-frail (with a frailty score lower than 3). Other recruitment requirements include being of any gender, race, and having medical clearance for exercise."

Answered by AI

Are there any opportunities for participation in this experiment?

"According to clinicaltrials.gov, this particular medical trial is not currently enrolling participants; the initial post was published on February 1st 2023 and it had its last update on November 14th 2022. However, there are 146 other studies that need patients right now."

Answered by AI

What goals are scientists hoping to accomplish with this experiment?

"The primary endpoint of this trial, measured over a 12-week period from baseline, will be levels of Interleukin 6. Secondary outcomes involve observation of the Amyloid beta 42/40 ratio, Brain Derived Neurotrophic Factor (BDNF), and Cognitive screen - SLUMS; these are assessed respectively through serum cognitive markers, picograms per milliliter readings for BDNF changes from pre- to posttreatment phases, and the VA – St Louis University Mental Survey which involves memory testing & shape recognition alongside Cognivue's visual reaction time test."

Answered by AI

Does this clinical research extend to geriatric individuals?

"This medical research is seeking out individuals aged between sixty and eighty-five for enrollment."

Answered by AI

Who else is applying?

What site did they apply to?
Kansas City VA Medical Center, Kansas City, MO
What portion of applicants met pre-screening criteria?
Met criteria

Why did patients apply to this trial?

I have a depression and sadness that I can’t control.
PatientReceived no prior treatments
~133 spots leftby Dec 2027